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Abstract
Purification of suitable quantity of homogenous protein is very often the bottleneck in protein structural studies.
Overexpression of a desired gene and attachment of enzymatically cleavable affinity tags to the protein of interest made a
breakthrough in this field. Here we describe the structure of Galleria mellonella silk proteinase inhibitor 2 (GmSPI-2)
determined both by X-ray diffraction and NMR spectroscopy methods. GmSPI-2 was purified using a new method consisting
in non-enzymatic His-tag removal based on a highly specific peptide bond cleavage reaction assisted by Ni(II) ions. The X-
ray crystal structure of GmSPI-2 was refined against diffraction data extending to 0.98 A˚ resolution measured at 100 K using
synchrotron radiation. Anisotropic refinement with the removal of stereochemical restraints for the well-ordered parts of the
structure converged with R factor of 10.57% and Rfree of 12.91%. The 3D structure of GmSPI-2 protein in solution was solved
on the basis of 503 distance constraints, 10 hydrogen bonds and 26 torsion angle restraints. It exhibits good geometry and
side-chain packing parameters. The models of the protein structure obtained by X-ray diffraction and NMR spectroscopy are
very similar to each other and reveal the same b2ab fold characteristic for Kazal-family serine proteinase inhibitors.
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Introduction
Despite significant methodological progress [1], structural
studies of proteins still require significant amount of pure samples.
To achieve this goal, the affinity tag methodology is commonly
used. However, the presence of an affinity tag may affect the
biological activity of a target protein and interfere with crystalli-
zation [2]. Therefore it is recommended to remove affinity tags
from the purified protein. This has often been, however, the
Achilles heel of this approach. The proteinase-mediated enzymatic
cleavage commonly used for affinity tag removal poses serious
risks, such as non-specific degradation of the target protein [3–5].
Moreover, costly preparative-scale purification of the cleavage
products is necessary, including the proteinase inactivation and
removal step. Chemical cleavage agents are suggested as
inexpensive alternative to proteolytic enzymes [6–8]. However,
none of them is commonly used due to their low specificity and
harsh reaction conditions [9–11].
Our previous studies demonstrated that Ni(II) ions hydrolyze
the peptide bond preceding the serine or threonine residue in (S/
T)XHZ peptide sequences [12]. The specificity of the cleavage was
confirmed for a range of peptides and the reaction mechanism was
precisely elucidated [13]. Recently we have positively verified the
biotechnological applicability of the Ni(II)-depended peptide bond
cleavage reaction for the recombinant GmSPI-2 protein, which is
the subject of our structural analysis in this work. The protein
purification procedures in that study were performed on an
analytical scale [14]. However those results indicated that the
methodology could be easily scaled up for preparative purification
of recombinant proteins for structural studies.
The GmSPI-2 protein is a structurally unique Kazal-family
serine proteinase inhibitor identified in the silk of wax moth
Galleria mellonella [15]. It is the shortest Kazal-family serine
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proteinase inhibitor in animals. Unlike most Kazal-family serine
proteinase inhibitors, where each functional domain consists of
50–60 amino acid residues with six conserved cysteines, GmSPI-2
is a single domain inhibitor of 36 residues with only four cysteines
(Fig. 1). Computer modeling suggested that, in contrast to typical
Kazal-family serine proteinase inhibitors, the conformation of
GmSPI-2 includes not three but only two loops which are
stabilized and closed into rings by disulfide bridges between the
four conserved cysteines [15]. The inhibitor exhibits high activity
against subtilisin and proteinase K (proteases from Bacillus subtilis
and the Tritirachium album, respectively) [15]. Recombinant
GmSPI-2 activity is identical with the native protein [16]. Since
GmSPI-2 is a much potent proteinase inhibitor than some
commercially available inhibitors (e.g. AEBSF, 4-(2-aminoethyl)
benzenesulfonyl fluoride hydrochloride; [17]), it could be used as a
replacement or supplement of available inhibitors or inhibitor
cocktails. Additionally, when fused to a target protein, GmSPI-2
could protect the target protein against proteinase degradation
[17,18]. Thus, GmSPI-2 can be considered as a valuable and
economically important protective tool in biotechnology for
enhancing the yields and prolonging the life of desired protein
products.
Here we discuss the application of the previously described
nickel-based purification methodology, scaled up for this structural
work, and demonstrate the usefulness of this innovative approach
for structural studies. The determinations of the atomic resolution
X-ray and high quality NMR structure of the GmSPI-2 protein,
both critically dependent on large quantities of highly pure protein
samples, were possible partially because of this protein purification
method.
Materials and Methods
GmSPI-2-SRHWAP-H6 fusion protein expression and
purification
The cDNA sequence encoding SPI-2 protein with modified C-
terminal end was used as a template (Leu codon was added as
described [16]). The primers were extended to introduce a PstI
restriction site at the 59 end of the amplified product and an XbaI
restriction site at the 39 end, followed nucleotides encoding
SRHWAP and six histidyl residues. The alternative SPI2-
SRHWAP-H6 fusion protein was designed in order to improve
the yield of purification and the purity of the final product. The
appropriate gene construct was successfully cloned under the
control of AOX promoter in a pPICZaB vector (Invitrogen), using
standard methods. As a result of the cloning procedure and the
pre-protein processing in Pichia pastoris, GmSPI-2 was extended
by the GluAlaAla- tripeptide at the N-terminus and by the -Leu40
residue at the C-terminus. The fusion protein secreted to the
media was initially purified by affinity chromatography on Ni-
NTA-agarose (Qiagen) in the presence of 20 mM phosphate
buffer pH 7.4, containing 0.5 M NaCl. The fusion protein was
then eluted from the column with 250 mM imidazole and dialyzed
overnight against water in order to remove the excess of salts.
Typically 2 ml of elution fraction was dialyzed against 2 L of
water. Next, the protein was purified by HPLC on a Vydac C18
semipreparative column. The eluting solvent A was 0.1% TFA/
water and solvent B was 0.1% TFA/90% acetonitrile/water. A
linear gradient of acetonitrile from 10% to 40% in 30 min was
applied at a flow rate of 2 mL/min, with detection at 220 nm and
280 nm. After elution, the fusion protein was frozen and
lyophilized. The HPLC purification step was applied to assess
the amount of GmSPI-2.
Affinity tag cleavage
The GmSPI-2 fusion protein after lyophilization was weighed
(portions of 5–7 mg) and dissolved in 20 mM phosphate buffer pH
7.4, containing 0.5 M NaCl and incubated with Ni-NTA-agarose
(Qiagen) for 2 h at 4uC. Then the GmSPI-2 fusion protein
immobilized on Ni-NTA agarose was incubated in 100 mM
Hepes buffer pH 8.2, containing 150 mM NaCl and 7.5 Mm
NiCl2 at 50uC for 19 h. The GmSPI-2 protein obtained in the
flow-through fraction was further purified using the Breeze HPLC
system (Waters) on a Vydac C18 semipreparative column. The
eluting solvent A was 0.1% TFA/water and solvent B was 0.1%
TFA/90% acetonitrile/water. A linear gradient of solvent B from
10% to 40% in 30 min was used at a flow rate of 2 mL/min. The
molecular mass of the collected HPLC single peak was measured
on a Q-Tof1 ESI MS spectrometer (Micromass).
Crystallization
Screening for crystallization conditions was performed manually
using Crystal Screen and Crystal Screen 2 [19] and the hanging-
drop vapor-diffusion technique at 292 K, by mixing 1 ml protein
(6.5 mg ml21 in water) and 1 ml reservoir solution. Needle-like
crystals grew to dimensions of 0.660.0560.05 mm within one
week over a reservoir solution consisting of 1.4 M sodium citrate
and 0.1 M Hepes pH 7.5 (Crystal Screen condition no. 38). For
cryoprotection, the crystal was transferred to a solution consisting
of the reservoir solution supplemented with 20% (v/v) glycerol.
X-Ray data collection
Diffraction data were measured at 100 K on a Rayonics MX-
225 CCD detector at beamline BL 14.1 of the Berliner
Elektronenspeicherring-Gesellschaft fu¨r Synchrotronstrahlung
m.b.H. (BESSY, Berlin). Integration, scaling and merging of the
intensity data was accomplished using the XDS package [20]. The
best crystal diffracted to 0.95 A˚ but due to a glitch of the data
collection program, only 52u of the high-resolution pass were
collected. Therefore, the low-resolution and truncated high-
resolution passes were scaled together with the data collected for
another crystal. This gave the complete data set at 0.98 A˚,
characterized in Table 1. An overall B-factor of 8.2 A2 was
Figure 1. Sequence alignment of classical (OMTKY3), non-classical group 1 (CrSPI-1-D1), non-classical group 2 (LDTI) and GmSPI-2
Kazal-family serine proteinase inhibitors. The alignment was calculated with ClustalW2 [46]. Cysteine residues are highlighted in yellow. Amino
acids identical in all four proteins are marked with an asterisk (*), conservative substitutions with a colon (:), and semi-conservative substitutions with
a period (.).
doi:10.1371/journal.pone.0106936.g001
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estimated from the Wilson plot using the XSCALE program from
XDS package [20].
Data measured to high resolution with a synchrotron X-ray
beam can be contaminated with effects of crystal radiation
damage. However, the plot of decay R factor [21] against frame-
number difference was around zero and scaling factors for the
individual diffraction images fluctuated around 1 without any
decreasing trend, indicating no or very little effect of radiation
damage. The data were also checked for diffraction anisotropy
[22]. A very low spread in values of the three principal
components (0.48 A˚2) indicated almost no anisotropy.
X-Ray structure solution and refinement
The structure was solved by molecular replacement using the
MOLREP program from the CCP4 suite [23,24] and the
structure of leech-derived tryptase inhibitor (LDTI; PDB code
1an1; [25]) as the search model. The amino-acid sequence of the
model shares 40% identity and 60% similarity (LALIGN; [26])
with GmSPI-2. The initial maximum-likelihood structure-factor
refinement was carried out in REFMAC [27] using all data, with
the exception of 1031 reflections (6%) flagged for cross-validation
purposes. No s cutoff was applied. The manual rebuilding of the
Table 1. X-ray data collection and model refinement statistics.
Data Collection
Crystal size (mm) 0.760.0560.05
Space group P212121
Unit cell parameters (A˚) a= 27.27, b= 31.24, c= 35.74
X-ray source BESSY 14.1
Temperature (K) 100
No. of images 360a/180/52
Oscillation angle (u) 1.0a/2.0/1.0
Wavelength (A˚) 0.91841a/0.80000/0.80000
Resolution (A˚) 20.00–0.98 (1.01–0.98)b
Rint
c(%) 7.2 (46.0)
,I/sI. 22.52 (2.04)
Reflections
measured 222092
unique 17179
in test set 1031
Mosaicity (u) 0.13
Completeness (%) 94.8 (84.5)
Redundancy 12.9 (2.3)
Wilson B-factor (A˚2) 8.2
Refinement
Resolution (A˚) 20.00–0.98 (1.02–0.98)
No. reflections 17179 (1790)
Rwork/Rfree
d 10.57/12.91
No. of atoms
protein 328
solvent 96
B-factors (A˚2)
protein 6.5
solvent 12.1
Rmsd from ideal
bond lengths (A˚) 0.023
angle distances (A˚) 0.058
Ramachandran statistics (%)
favored 90.6
additional 9.4
PDB code 4hgu
aValues for crystal no. 1.
bValues in parentheses are for the highest resolution shell.
cRint =ShklSi|Ii(hkl)2,I(hkl).|/ShklSi Ii(hkl), where Ii(hkl) is the ith measurement of the intensity of reflection hkl and ,I(hkl). is the mean intensity of reflection hkl.
dR=S||Fo|2|Fc||/S|Fo|, where Fo and Fc are the observed and calculated structure factor amplitudes, respectively.
doi:10.1371/journal.pone.0106936.t001
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model was performed in COOT [28]. The conjugate-gradient
least-squares refinement in SHELXL [29] was used to refine the
model at the later stages. The main steps of the refinement
included (1) isotropic refinement with manually added water
molecules and sodium ions, (2) anisotropic refinement, (3) addition
of H atoms according to geometrical criteria implemented in
SHELXL, (4) refinement of the occupancies of partially occupied/
alternate conformations and solvent atoms, and finally (5) removal
of the restraints for the well-ordered parts of the model. Six side-
chains, namely Glu1, 8 and 38, Val4, Asp10 and Leu23, as well as
two Ca atoms, of Val4 and Glu38, were modeled with alternate
conformations. Additionally, the Cc, Cd, Oe1 and Oe2 atoms of
Glu36, and the Ce and Nf atoms of Lys15 and Lys18 were given
partial occupancies. The stereochemical restraints were retained
throughout refinement only for these side chains/atoms.
Sodium ions were found in the electron density map and
identified on the basis of coordination number (6) and Na+ ? ? ? O
distances (2.33–2.58 A˚), in agreement with the high concentration
of sodium cations in the crystallization solution (1.4 M sodium
citrate). In the final round, all data were used in the refinement,
including the Rfree reflections, leading to the convergence with R
values of 8.62% for the 14133 reflections with Fo.4s(Fo) and
10.57% for all 17179 reflections (Table 1).
At the end of the refinement, one cycle of full-matrix
minimization was calculated with all stereochemical restraints
removed and with all parameter shifts damped to zero, which
permitted the estimation of the standard uncertainties (s.u.) in all
positional parameters. Full refinement statistics are given in
Table 1.
NMR resonance assignment and structure determination
All NMR experiments were performed using an 18.8 T Varian
DirectDrive 800 NMR spectrometer (operating 1H frequency
799.811 MHz). The NMR sample was obtained by diluting a
GmSPI-2 protein sample in 90%/10% H2O/D2O, 20 mM
phosphate buffer pH 4.5, with 50 mM NaCl, to a final
concentration of 0.5 mM. Assignments of 1H, 13C, and 15N
resonances were achieved utilizing standard methods on the basis
of 2D TOCSY and NOESY data [30]. The homonuclear
experiments were supplemented with 2D heteronuclear 1H-15N
and 1H-13C HSQC spectra acquired at natural abundance of 15N
and 13C nuclei. All NMR spectra were referenced using external
DSS (sodium 2,29-dimethyl-2-silapentane-5-sulfonate) [31] and
processed by NMRPipe software [32]. The three-dimensional
structure of the GmSPI-2 protein in solution was solved by
standard 2D NMR techniques on the basis of 503 (141 intra-
residue, 138 sequential, 84 medium, and 140 long range) distance
constraints provided by the analysis of 2D homonuclear 1H-1H
NOESY spectra acquired with 120 ms mixing time. 26 Restraints
for the backbone Q and y torsion angles were defined using the
analysis of chemical shifts with the program TALOS+ [33]. This
procedure provided 58 restraints for the Q and y torsion angles for
29 residues, which were predicted as ‘good’ by TALOS+.
Additionally, 20 distance constraints for 10 hydrogen bonds were
defined as rHN-O = 1.5–2.8 and rN-O = 2.4–3.5 A˚ (Table 2). 200
structures were calculated by the CYANA (version 3.0) software
[34]. Finally, 17 conformers, selected on the basis of low target
function criteria, were subjected to a refinement procedure in a
water shell using the YASARA program suite [35]. The statistics of
NOE distance restraints together with the analysis of the ensemble
of 17 lower energy structures evaluated on the basis of NMR data
are presented in Table 2.
Results and Discussion
Purification of GmSPI-2 protein for structural studies
The fusion construct designed for the affinity purification/tag
removal approach according to our nickel-based method, contains
the Ni(II)-specific SRHW sequence cloned between the GmSPI-2
target protein and its C-terminal His-tag. Two additional amino
acids, Ala and Pro, were added after the crucial tetrapeptide
sequence as a spacer in order to avoid unwanted interactions
between this sequence and the tag. The purification procedure of
the GmSPI-2-SRHWAP-H6 fusion protein produced in Pichia
pastoris culture, included initial affinity chromatography on Ni-
NTA agarose, followed by HPLC. The latter purification step was
applied in order to assess the amount of the fusion protein for
affinity tag removal, thus enabling a quantitative evaluation of this
novel procedure at the preparative scale of 5–7 mg of protein. The
purified GmSPI-2-SRHWAP-H6 protein was then reloaded on the
Ni-NTA agarose column, and incubated with excess of Ni(II) ions.
The cleavage conditions were based on our recently published
analytical-scale paper [14]. The flow-through fraction collected
contained only the pure GmSPI-2 protein, with the SRHWAP-H6
tag removed, as evidenced by the presence of a single peak on the
HPLC chromatogram of this fraction (Fig. 2). A chromatogram of
the wash buffer fraction indicated that a small amount of GmSPI-2
got stuck to the agarose column. The molecular masses of the
collected peaks confirmed the absence of unspecific cleavage. The
total yield of pure GmSPI-2 was 70% in repeated experiments.
The efficiency of the cleavage reaction was calculated precisely
using the values of HPLC peak areas corresponding to the
substrate and products before and after protein incubation with
Ni(II) ions.
The quality of the crystal structure
The final crystallographic GmSPI-2 model (PDB code 4hgu)
consists of 328 protein-atom sites for 300 non-hydrogen atoms, 92
water molecules and 4 sodium ions. The electron density for all
atoms of the main-chain and fully occupied atoms of side-chains is
exceptionally good. The number of reflections per parameter in
the final cycle of refinement was 4.5, sufficient to justify refinement
without any stereochemical restraints for the well-ordered parts of
the molecule. Despite this radical approach, 90.6% of the residues
are located in the most favored regions and 9.4% in the
additionally allowed regions of the Ramachandran plot [36].
This, together with very good refinement statistics, confirmed that
this refinement approach was correct.
The average value of the atomic displacement parameter (Beq)
for GmSPI-2 is 6.5 A˚2. The N/C termini in protein structures are
very often disordered. The pattern of Beq values along the
polypeptide chain shows that the whole main chain is well ordered
(Fig. 3). Especially the residues from 11 to 14 (forming b-strand 1)
and from 19 to 33 (forming b-strand 2 and a-helix) have slightly
lower than average Beq value (with Beq values of 3.53 and 3.75 A˚
2
for residues 11–14 and 19–33, respectively). The mean Beq values
of the main-chain, side-chain and solvent atoms of GmSPI-2 are
4.8, 8.2 and 12.1 A˚2, respectively. There are only two structures of
Kazal-family serine proteinase inhibitors determined at a compa-
rable resolution which are available in the PDB, namely 1r0r at
1.10 A˚ and 2 gkr at 1.17 A˚. The corresponding values of Beq for
those structures are much higher, 16.7, 19.3 and 38.2 A˚2 for 1r0r
and 14.4, 17.0 and 32.6 A˚2 for 2 gkr, respectively.
The estimated values of s.u. in all positional parameters for the
fully occupied main-chain atoms range from 0.012 A˚ to 0.033 A˚
(Fig. 4). It is evident from Fig. 4 that coordinate errors have
smaller values for ‘heavier’ atoms, e.g. oxygen, and slightly higher
Structure of GmSPI-2 Inhibitor
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for nitrogen and carbon atoms. The s.u. values for the major
conformation of the two main-chain atoms refined in two
conformations are much higher, 0.048 A˚ for the Ca atom of
Ala4 and 0.054 A˚ for the Glu38. A similar pattern was observed
for the coordinate errors estimated for the structure of lysozyme
refined at 0.65 A˚ resolution [37] or BPTI refined at 0.86 A˚ [38].
The quality of the crystallographic model can also be assessed
using the statistics of the derived geometrical parameters. For
instance, the peptide C = O bond lengths (range from 1.19 to 1.28
A˚, with a mean of 1.23 A˚) are characterized by standard
uncertainties between 0.01 and 0.03 A˚, with a mean of 0.02 A˚.
These statistics are almost identical to those reported for squash
trypsin inhibitor (CMTI-I) studied at a comparable resolution of
1.03 A˚ [39]. However, the model of CMTI-I was refined with the
BUMP and geometrical restraints retained on main-chain
segments with excessive displacement parameters (with Beq.15
A˚).
Crystal packing and intermolecular contacts
The GmSPI-2 molecules are densely packed with only 30.2%
volume being occupied by solvent (the corresponding Matthews
coefficient is 1.76 A˚3/Da). All other Kazal-family serine proteinase
inhibitors are more loosely packed, with the solvent content
ranging from 31.9% (for N-terminally truncated turkey ovomucoid
third domain, OMTKY3; PDB code 2 gkr) to 54.0% (for infestin
4; 2erw). The GmSPI-2 molecules are more solvent exposed along
the crystallographic b axis (Fig. 5). There are 7 intermolecular
hydrogen bonds, listed in Table 3. Two of them, linking molecules
related by the 21 screw along [001] involve atoms with partial
occupancy. The hydrogen bond involving the Cys24 N atom
should be regarded as week due to an unfavorable angle and the
presence of another hydrogen acceptor from the preceding Asn22
Od1 atom. Besides direct hydrogen bonds, water molecules play a
profound role in mediating intermolecular contacts. An example
of this is the N-terminus where the Glu1 N atom is anchored to
two symmetry related GmSPI-2 molecules by hydrogen bonds
through three well-ordered water molecules 203, 204 and 226 with
B-factors (A˚2)/donor-acceptor distances (A˚) of 7.30/2.85, 7.99/
2.82 and 6.27/2.70, respectively. Moreover, the first three N-
terminal residues, which in fact are artificial to the native GmSPI-2
sequence, form only indirect intermolecular interactions through
Table 2. NMR restraints and structural statistics for the ensemble of 17 lower energy of GmSPI-2 conformers.
NOESY distance restraintsa 506
intraresidual (|i-j| = 0) 135
sequential (|i-j| = 1) 135
medium-range (1,|i-j| #5) 77
long-range (|i-j|.5) 135
Hydrogen bonds 24
Constraints per residue 13.3
Torsion angle restraints
backbone (Q/y) 26
Structure Z-scores
1-st generation packing quality 20.12561.034
2-nd generation packing quality 4.83661.836
Ramachandran plot appearance 20.92360.405
x1/x2 rotamer normality 22.53860.874
Backbone conformation 0.18960.470
RMS Z-scoresb
bond lengths 1.17460.008
bond angles 0.51360.021
omega angle restraints 0.92960.115
side chain planarity 0.67360.117
improper dihedral distribution 0.87860.099
Ramachandran statisticsc (%)
favored 86.9
additional 13.1
Rmsd from the mean structure
backbone atoms (A˚) 0.6360.27
heavy atoms (A˚) 0.9660.20
PDB code 2m5x
number of models 17
aNone of the 17 structures has a distance violation of more than 0.2 A˚ and a dihedral angle violation more than 5u.
bThe quality of the ensemble of 17 lowest-energy structures was checked by PROCHECK-NMR, version 3.4 [48].
cThe ensemble of structures was validated by the WhatIf program [49].
doi:10.1371/journal.pone.0106936.t002
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Figure 2. Preparative HPLC chromatograms of protein samples after 19 h of incubation at 506C. Incubation buffer (top) and wash buffer
(bottom). The peak labels denote the reaction substrate and products, identified using ESI-MS: P, pure GmSPI-2 protein (4310 Da); T, the SRHWAP-H6
peptide (the extended His-tag, which is the C-terminal hydrolysis product, 1574 Da); S, substrate (fusion protein, 5868 Da).
doi:10.1371/journal.pone.0106936.g002
Figure 3. Plot of Beq averaged over main-chain (green) and side-chain (orange) atoms of the crystallographic model. Values of zero in
the lower plot correspond to glycines.
doi:10.1371/journal.pone.0106936.g003
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water molecules and a sodium ion. The first direct intermolecular
hydrogen bond is made by the Val4 O atom (Table 3).
The crystal structure includes four partially occupied sodium
ions. Two of them, namely Na101 and Na102 have complete
octahedral coordination spheres. The coordination number of
Na103 and Na104 is 5 and 4, respectively. These sodium ions are
coordinated by oxygen atoms belonging to the GmSPI-2 molecule
(Thr7 Oc1, Asp16 O and Asp34 O and Od1), as well as by water
molecules. It has not escaped our notice that two sodium ions,
namely Na103 and symmetry related Na104 (2x, K+y, K2z),
are 3.14 A˚ apart sharing two symmetry related water molecules
257 and 258 (2x, K+y, K2z) in their coordination spheres.
Similar arrangement is often found in small molecule structures. In
the structure of catena-(hexakis(m2-Aqua)-di-sodium 2,5-dibenzoyl-
terephthalate tetrahydrate) (CSD reference code HAYQUU) [40]
Na1 and Na2 ions are 3.14 A˚ apart and share three water
molecules (O4, O5 and O6) in their coordination spheres.
Description of the GmSPI2 structure
The overall structure of GmSPI-2 (Fig. 6A) resembles that of
other Kazal-family serine proteinase inhibitors. Residues Val12-
Gly14, Thr19-Tyr20 and Leu33-Glu36 form an anti-parallel b-
sheet while residues Leu23-Ala29 form the central a-helix of the
characteristic Kazal-family serine proteinase inhibitor b2ab fold.
GmSPI-2 shows, however, features of non-classical Kazal-family
serine proteinase inhibitors, harboring an unusual pattern of
Figure 4. Coordinate errors for main-chain atoms estimated from the inversion of the least-squares matrix. For dual-occupancy atoms,
only the major component is plotted.
doi:10.1371/journal.pone.0106936.g004
Table 3. Direct protein-protein intermolecular hydrogen bonds in the GmSPI2 crystal structure.
No Residue, atom Residue, atom
Distance
(A˚)
1 Val4, O Gly32(a), N 2.83
2 Thr6, N Gly30(a), O 2.90
3 Cys24, N Ala29(a), O 3.06
4 Ser21, N Leu40(b), OXT 2.77
5 Ser21, Oc Leu40
(b), O 2.58
6 Glu8, Oe2 Lys15
(c), Nf 2.42
7 Asn27, Nd2 Glu38
(c), Oe1 3.07
(a)x +K, 2y + K, 2z.
(b)2x, y + K, 2z+K.
(c)2x+K, 2y, z+K.
doi:10.1371/journal.pone.0106936.t003
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disulfide bridges. Only two intradomain disulfide bridges formed
between Cys residues 5 and 24 and Cys residues 13 and 39 are
present. GmSPI-2 has been classified as a non-classical Kazal-
family serine proteinase inhibitor group 1 [41]. This group of
inhibitors is characterized by the shift of the first and the fifth half-
cystine residues towards the C-terminus with respect to classical
Kazal-family serine proteinase inhibitors [42]. A superposition of
the X-ray structure of GmSPI-2 with a classical Kazal-family
serine proteinase inhibitor (OMTKY3, 2 gkr), a group 1 non-
classical Kazal-family serine proteinase inhibitor (CrSPI-1-D1,
3pis) and a group 2 non-classical Kazal-family serine proteinase
inhibitor (LDTI, 1an1) shows that it resembles the structure of
LDTI (Fig. 7) with a root-mean-square deviation (rmsd) of 0.92 A˚
for 37 superimposed Ca atoms [43]. CrSPI-1-D1 like GmSPI-2 has
only two disulfide bridges. Both structures are similar up to Asp34
of GmSPI-2, but very different from there, till the very C-terminus.
Residues Trp34-Cys37 of CrSPI-1-D1 form a 310-helix, which is
not present in the structure of GmSPI-2.
The fully exposed reactive site loop (RSL) of the inhibitor
presents the P1 site with the Thr7 residue. The size of the GmSPI-
2 RSL is typical for Kazal-family serine proteinase inhibitors, with
seven amino acids between Cys5 and Cys13. It is generally
thought that the rigidity of the RSL together with its specific
sequence are the key factors conferring high potency on Kazal-
family serine proteinase inhibitors [41]. There are usually eight
hydrogen bonds stabilizing the RSL of Kazal-family serine
proteinase inhibitors [25,44]. The GmSPI-2 RSL has an additional
strong (2.86 A˚) hydrogen bond stabilizing the RSL between Thr6
(O) and Trp25 (Ne). Amongst Kazal-family serine proteinase
inhibitors a tryptophan residue in this position is present only in
GmSPI-2 [45].
The His-tag cleavage site was located between Leu40, and
Ser41 of the fusion protein. The 2Fo-Fc electron density map for
Leu40 is excellent for both the main-chain and side-chain atoms
including the C-terminal oxygen atoms O and OXT (Fig. 8). The
C-terminus is anchored by three strong hydrogen bonds involving
both carboxylic oxygen atoms. Two of them are listed in Table 3.
The third one involves the Leu40 OXT and Wat209 (x, y-1, z)
atoms. This further confirms the sequence specificity of the
presented tag cleavage procedure.
The structure of the GmSPI-2 protein in solution
determined by nmr spectroscopy
The three-dimensional structure of GmSPI-2 in solution was
determined by NMR spectroscopy using 503 distance constraints
derived from the analysis of 2D 1H-1H NOESY data sets. The
ensemble of 17 lowest-energy structures (PDB code 2m5x) selected
from a total of 200 calculated models is characterized by good
convergence and low rmsd from ideal geometry (Table 2). The
NMR-evaluated 3D structure is similar to that determined by X-
ray crystallography, and contains the same a (Leu23-Ala29) and b
(Val12-Gly14, Thr1-Tyr20, Leu33-Glu36) elements folded into
the b2ab motif of the hydrophobic core of the protein (Fig. 6B). A
least-squares superposition of the 34 Ca atoms of the Cys5-Glu38
segment of the crystallographic model and the NMR conformer
11, representing the NMR ensemble, is characterized by an rmsd
of 0.89 A˚. Upon detailed inspection, the indole group of Trp25
and the imidazole ring of His35 are found to be in different
orientations in the two models. Specifically, the x2 torsion angle of
Figure 5. Crystal packing of GmSPI-2 molecules viewed down the crystallographic b axis.
doi:10.1371/journal.pone.0106936.g005
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Trp25 differs by 30u between the X-ray and NMR structures. In
effect, the Trp25 Ne? ? ?Thr6 O hydrogen bond observed in the
crystal structure is not present in solution. Likewise, the His35
Hd1? ? ? Glu36 O hydrogen bond is broken in solution due to
reorientation of the His35 ring from x1 of 240u (gauche2) to +60u
(gauche+). Some minor conformational differences observed at the
N-termini can be attributed to crystallographic packing.
Methodological remarks
The applicability of our method is based on the assumption that
Ni(II) ions can interact with -SRHW-like sequences only at solvent
exposed tags. Otherwise we would be posed with unspecific
protein cleavage by Ni(II) ions. In previous study we verified the
crucial assumption that Ni(II) ions would not be able to penetrate
protein interiors or distort secondary structure elements using
human ubiquitin. This protein naturally possesses the potentially
active Thr-Leu-His-Leu sequence. However, despite prolonged
incubations in the presence of Ni(II) ions at elevated temperatures
no cleavage was observed for the natively folded protein, while Ubi
denaturated by GuHCl was hydrolyzed [14].
The results obtained by X-ray crystallography and NMR
spectroscopy consistently demonstrate that the molecular structure
of GmSPI-2 is highly similar in solution and in the crystalline state.
However, several small differences could be still detected. For
instance, the exact conformation of the two disulfide bridges could
not be unambiguously determined from the NMR data due to
insufficient concentration of the GmSPI-2 protein in solution. The
conformation of the first four N-terminal residues is different in the
two structures as a result of crystal packing interactions, i.e.
absence of intermolecular hydrogen bonds in solution.
His-tag and other small affinity tags are routinely used to obtain
pure recombinant proteins, and structural studies in solution are
often conducted without tag removal. This is, however, often
impossible in the solid state because the crystal packing can lead to
non-native interactions between the tag and the rest of the
molecule. Therefore, the quality of X-ray data strongly depends
on the homogeneity of the protein material, that is on the efficacy
of the tag removal procedure and on the absence of non-specific
cleavage products, which are usually generated by proteolytic
enzymes. In this perspective, the high resolution of the X-ray
diffraction data obtained in this work can be related to the truly
perfect removal of the affinity tag afforded by the nickel-based
methodology. Furthermore, the high yield of this method on the
preparative scale (conversion of 70% of the starting material to the
final product, with 100% homogeneity) makes it a good tool for
obtaining pure thermostable proteins for structural studies.
The short GmSPI-2 gene is a promising target for mutagenesis
directed toward engineering novel variants of the protein, specific
for selected serine proteinases (study in progress). Such a study
must be based on the precise knowledge of the starting polypeptide
structure. Only with such knowledge one can carry out rational
modeling and docking studies of GmSPI-2 derivatives to identify
suitable hits for overexpression and activity evaluation. A clear
understanding of the relation between the polypeptide structures
in the crystal and in solution is also a prerequisite for the validity of
such an approach. In this perspective, the accurate structure of this
unique polypeptide belonging to non-classical Kazal-family serine
proteinase inhibitors, by two methods, has to be regarded as
setting the stage for further studies. It is worth mentioning that in a
set of biologically interesting proteins, short domains with varying
Figure 6. The overall X-ray (A) and NMR (B) models of GmSPI-2. (A) b-stands and disulfides are shown in yellow, a-helix in red and loops in
green. (B) The ensemble of 17 lowest energy conformers are shown in different colors, with disulfides in yellow. The figure was prepared using PyMOL
[47].
doi:10.1371/journal.pone.0106936.g006
Figure 7. Stereo Ca tracing of the crystallographic model of GmSPI-2 (yellow) superimposed with the NMR structure of GmSPI-2 in
solution (conformer 11, magenta), CrSPI-1-D1 (red, PDB code 3pis), OMTKY3 (blue, 2 gkr) and LDTI (green, 1an1). The superposition
was calculated in Coot (Emsley & Cowtan, 2004) using the SSM algorithm and displayed in PyMOL [47].
doi:10.1371/journal.pone.0106936.g007
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homology to GmSPI-2 seem to be frequently present at either the
N- or the C-terminus (Kaczanowski & Zago´rski, unpublished).
Prediction of the probable function of such domains will be
facilitated by the present results, which have defined the structural
properties of a bona-fide inhibitor.
Conclusions
In the present study, the GmSPI-2 protein sequence was
extended C-terminally by an -SRHWAP-H6 dodecapeptide,
which comprises the underlined Ni(II)-sensitive tetrapeptide linked
to the His-tag domain. The fusion protein was expressed in Pichia
pastoris and affinity purified on Ni-NTA columns. The cleavage of
the tag directly on the Ni-NTA column enabled us to combine the
affinity purification and the tag removal into one step. The
GmSPI-2 protein obtained in flow-through fractions exhibited
100% homogeneity. The absolute sequence specificity of the
cleavage, observed previously in analytical scale purifications, has
been preserved on the preparative scale as well. No protein
impurities whatsoever could be detected in the protein fractions
tested by HPLC and ESI-MS. The efficiency of cleavage was 70%
on the preparative scale. The resulting GmSPI-2 protein was fully
active. The results obtained by X-ray crystallography and NMR
spectroscopy show that the structure of GmSPI-2 is highly similar
in solution and in the crystalline state. The resolution of the crystal
structure of 0.98 A˚ is the highest for the Kazal-type serine protease
inhibitors deposited in the PDB. The number of reflections per
parameter justified refinement without any stereochemical re-
straints for the well-ordered parts of the inhibitor. The refinement
converged with R= 10.57% for all reflections. One cycle of full-
matrix minimization permitted the estimation of the standard
uncertainties in all positional parameters which, for example, for
the fully occupied main-chain atoms range from 0.012 A˚ to 0.033
A˚. The 2Fo-Fc electron density map for Leu40, the last residue of
the mature inhibitor, is excellent for both the main-chain and side-
chain atoms including the C-terminal oxygen atoms O and OXT.
This clearly confirms the sequence specificity of the presented tag
cleavage procedure.
These exceptionally high grade of the protein purification
product was reflected in the high quality of the structural
determinations, both in the solid state and in solution. The high
resolution of these structures was certainly facilitated by the perfect
homogeneity of the protein sample after affinity tag removal.
Author Contributions
Conceived and designed the experiments: EK IZ SK. Performed the
experiments: EK IZ SK MLZˇ. Analyzed the data: EK IZ SK WB.
Contributed reagents/materials/analysis tools: MLZˇ AD BK KG.
Contributed to the writing of the manuscript: EK WB IZ MJ SK KG
WZO.
References
1. Wlodawer A, Minor W, Dauter Z, Jaskolski M (2013) Protein crystallography for
aspiring crystallographers or how to avoid pitfalls and traps in macromolecular
structure determination. FEBS J 280: 5705–5736.
2. Wojtkowiak A, Witek K, Hennig J, Jaskolski M (2012) Two high-resolution
structures of potato endo-1,3-b-glucanase reveal subdomain flexibility with
implications for substrate binding. Acta Crystallogr D Biol Crystallogr 68: 713–
723.
Figure 8. The C-terminus of the crystallographic model of GmSPI-2, residues Cys39 and Leu40, and symmetry-related Tyr20 and
Ser21 residues. The 2Fo-Fc electron density map was contoured at 1.4 s. Hydrogen bonds are shown as dash lines.
doi:10.1371/journal.pone.0106936.g008
Structure of GmSPI-2 Inhibitor
PLOS ONE | www.plosone.org 10 September 2014 | Volume 9 | Issue 9 | e106936
3. Choi SI, Song HW, Moon JW, Seong BL (2001) Recombinant enterokinase light
chain with affinity tag: expression from Saccharomyces cerevisiae and its utilities
in fusion protein technology. Biotechnol Bioeng 75: 718–24.
4. Jenny RJ, Mann KG, Lundblad RL (2003) A critical review of the methods for
cleavage of fusion proteins with thrombin and factor Xa. Protein Expr Purif 31:
1–11.
5. Waugh DS (2011) An overview of enzymatic reagents for the removal of affinity
tags. Protein Expr Purif 80: 283–93.
6. Milovic´ NM, Dutca LM, Kostic´ NM (2003) Transition-metal complexes as
enzyme-like reagents for protein cleavage: complex cis-[Pt(en)(H2O)2]
2+ as a new
methionine-specific protease. Chem Eur J 9: 5097–5106.
7. Allen G, Campbell O (1996) Specific cleavage of histidine-containing peptides
by copper(II). Int J Peptide Protein Res 48: 265–273.
8. Yashiro M, Yamamura A, Takarada T, Komiyama M (1997) Sequence-specific
hydrolysis of peptides by metal assisted autocatalysis of an internal hydroxyl
group. J Inorg Biochem 67: 225.
9. Humphreys DP, Smith BJ, King LM, West SM, Reeks DG, et al. (1999) Efficient
site-specific removal of C-terminal FLAG fusion from Fab’ using copper(II) ion
catalyzed protein cleavage. Protein Eng 12: 179–184.
10. Humphreys DP, King LM, West SM, Chapman AP, Sehdev M, et al. (2000)
Improved efficiency of site-specific copper(II) ion-catalyzed protein cleavage
effected mutagenesis of cleavage site. Protein Eng 13: 201–206.
11. Dou F, Qiao F, Hu J, Zhu T, Xu X, et al. (2000) Preliminary study on the
cleavage of fusion protein GST-CMIV with palladium(II) complex. Prep
Biochem Biotechnol 30: 69–78.
12. Kre˛z_el A, Kopera E, Protas AM, Poznan´ski J, Wysłouch-Cieszyn´ska A, et al.
(2010) Sequence-specific Ni(II)-dependent peptide bond hydrolysis for protein
engineering. Combinatorial library determination of optimal sequences. J Am
Chem Soc 132: 3355–3366.
13. Kopera E, Kre˛z_el A, Protas AM, Belczyk A, Bonna A, et al. (2010) Sequence-
specific Ni(II)-dependent peptide bond hydrolysis for protein engineering:
reaction conditions and molecular mechanism. Inorg Chem 49: 6636–6645.
14. Kopera E, Belczyk-Ciesielska A, Bal W (2012) Application of Ni(II)-assisted
peptide bond hydrolysis to non-enzymatic affinity tag removal. PLoS One 7:
e36350.
15. Nirmala X, Kodrik D, Zurovec M, Sehnal F (2001) Insect silk contains both a
Kunitz-type and a unique Kazal-type proteinase inhibitor. Eur J Biochem 268:
2064–2073.
16. Kludkiewicz B, Kodrik D, Grzelak K, Nirmala X, Sehnal F (2005) Structurally
unique recombinant Kazal-type proteinase inhibitor retains activity when
terminally extended and glycosylated. Protein Expr Purif 43: 94–102.
17. Milner M, Chroboczek J, Zago´rski W (2007) Engineered resistance against
proteinases. Acta Biochim Pol 54: 523–536.
18. Redkiewicz P, Wie˛syk A, Go´ra-Sochacka A, Sirko A (2012) Transgenic tobacco
plants as production platform for biologically active human interleukin 2 and its
fusion with proteinase inhibitors. Plant Biotechnol J 10: 1–9.
19. Jancarik J, Kim SH (1991) Sparse matrix sampling: a screening method for
crystallization of proteins. J Appl Crystallogr 24: 409–411.
20. Kabsch W (1993) Automatic processing of rotation diffraction data from crystals
of initially unknown symmetry and cell constants. J Appl Crystallogr 26: 795–
800.
21. Diederichs K (2006) Some aspects of quantitative analysis and correction of
radiation damage. Acta Crystallogr D Biol Crystallogr 62: 96–101.
22. Strong M, Sawaya MR, Wang S, Phillips M, Cascio D (2006) Toward the
structural genomics of complexes: crystal structure of a PE/PPE protein complex
from Mycobacterium tuberculosis. Proc Natl Acad Sci U S A 103: 8060–8065.
23. Vagin A, Teplyakov A (1997) MOLREP: an Automated Program for Molecular
Replacement. J Appl Crystallogr 30: 1022–1025.
24. Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, et al. (2011)
Overview of the CCP4 suite and current developments. Acta Crystallogr D Biol
Crystallogr 67: 235–242.
25. Lee T-W, Qasim Jr MA, Laskowski M, James NG (2007) Structural insights into
the non-additivity effects in the sequence-to-reactivity algorithm for serine
peptidases and their inhibitors. J Mol Biol 367: 527–546.
26. Huang X, Miller W (1991) A time-efficient linear-space local similarity
algorithm. Adv Appl Math 12: 337–357.
27. Murshudov GN, Vagin AA, Dodson EJ (1997) Refinement of macromolecular
structures by the maximum-likelihood method. Acta Crystallogr D Biol Crystal-
logr 53: 240–255.
28. Emsley P, Cowtan K (2004) Coot: model-building tools for molecular graphics.
Acta Crystallogr D Biol Crystallogr 60: 2126–2132.
29. Sheldrick GM (2008) A short history of SHELX. Acta Crystallogr A Found Adv
64: 112–122.
30. Wu¨thrich K (1986) NMR of Proteins and Nucleic Acids. Wiley, New York. 166
p.
31. Wishart DS, Bigam CG, Yao J, Abildgaard F, Dyson HJ, et al. (1995) 1H, 13C
and 15N chemical shift referencing in biomolecular NMR. J Biomol NMR 6:
135–140.
32. Delaglio F, Grzesiek S, Vuister GW, Zhu G, Pfeifer J, et al. (1995) NMRPipe: a
multidimensional spectral processing system based on UNIX pipes. J Biomol
NMR 6: 277–293.
33. Shen Y, Delaglio F, Cornilescu G, Bax A (2009) TALOS+: a hybrid method for
predicting protein backbone torsion angles from NMR chemical shifts. J Biomol
NMR 44: 213–223.
34. Gu¨entert P, Mumenthaler K, Wu¨thrich K (1997) Torsion angle dynamics for
NMR structure calculation with the new program DYANA. J Mol Biol 273:
283–298.
35. Krieger E, Koraimann G, Vriend G (2002) Increasing the precision of
comparative models with YASARA NOVA–a self-parameterizing force field.
Proteins 47: 393–402.
36. Ramachandran GN, Sasisekharan V (1968) Conformation of polypeptides and
proteins. Adv Protein Chem 23: 283–437.
37. Wang J, Dauter M, Alkire R, Joachimiak A, Dauter Z (2007) Triclinic lysozyme
at 0.65 A˚. Acta Crystallogr D Biol Crystallogr 63: 1254–1268.
38. Addlagatta A, Czapinska H, Krzywda S, Otlewski J, Jaskolski M (2001)
Ultrahigh-resolution structure of a BPTI mutant. Acta Crystallogr D Biol
Crystallogr 57: 649–663.
39. Thaimattam R, Tykarska E, Bierzynski A, Sheldrick GM, Jaskolski M (2002)
Atomic resolution structure of squash trypsin inhibitor: unexpected metal
coordination. Acta Crystallogr D Biol Crystallogr 58: 1448–61.
40. Wang D-D, Zhu H-J, Song G-L, Wang J-T (2005) Bis(triaquasodium) 2,5-
dibenzoylterephthalate tetrahydrate. Acta Crystallogr Sect E Struct Rep Online
61: m2610–m2612.
41. Shenoy RT, Thangamani S, Velazquez-Campoy A, Ho B, Ding JL (2011)
Structural basis for dual-inhibition mechanism of a non-classical Kazal-type
serine protease inhibitor from horseshoe crab in complex with subtilisin. PloS
One 6: e18838.
42. Hemmi H, Kumazaki Yoshizawa-Kumagaye K, Nishiuchi Y, Yoshida T,
Ohkubo T, et al. (2005) Structural and functional study of an Anemonia elastase
inhibitor, a ‘‘nonclassical’’ Kazal-type inhibitor from Anemonia sulcata.
Biochemistry 44: 9626–9636.
43. Cohen GH (1997) ALIGN: a program to superimpose protein coordinates,
accounting for insertions and deletions. J Appl Crystallogr 30: 1160–1161.
44. Di Marco S, Priestle JP (1997) Structure of the complex of leech-derived tryptase
inhibitor (LDTI) with trypsin and modeling of the LDTI-tryptase system.
Structure 5: 1465–1474.
45. Rimphanitchayakit V, Tassanakajon A (2010) Structure and function of
invertebrate Kazal-type serine proteinase inhibitors. Dev Comp Immunol 34:
377–386.
46. Larkin MA, Blackshields G, Brown NP, Chenna R, McGettigan PA, et al. (2007)
Clustal W and Clustal X version 2.0. Bioinformatics 23: 2947–2948.
47. DeLano WL (2002) DeLano Scientific, San Carlos, CA, USA.
48. Laskowski RA, Rullmannn JA, MacArthur MW, Kaptein R, Thornton JM
(1996) AQUA and PROCHECK-NMR: programs for checking the quality of
protein structures solved by NMR. J Biomol NMR 8: 477–486.
49. Vriend G (1990) WHAT IF: A molecular modeling and drug design program.
J Mol Graph 8: 52–56.
Structure of GmSPI-2 Inhibitor
PLOS ONE | www.plosone.org 11 September 2014 | Volume 9 | Issue 9 | e106936
